Brief: Rallybio Q4 Net Income USD -11.044 Million
13/03/2025 12:00
Mar 13 (Reuters) - Rallybio Q4 operating expenses USD 11.646 million. Q4 basic EPS USD -0.25 Q4 income from operations USD -11.608 million
Recent news on Rallybio
See all newsNASDAQ RESUMED AT 08:48 AM
Brief: Rallybio Corporation And Avenzo Therapeutics Announce Merger Agreement To Advance Next-Generation Oncology Therapies And $215 Million Concurrent Private Placement
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE-Mirum Pharma
U.S. STOCKS ON THE MOVE-Mirum Pharma, eBay, FedEx